Tsubota Laboratory Incorporated (4890.T)
JPY 397.0
(-3.41%)
JPY 397.0
(-3.41%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | -301.35 Million | 28.49 Million | 654.91 Million | 36.72 Million | 262.83 Million |
| Net Income | -636.37 Million | 144.22 Million | 202.34 Million | 255.83 Million | 3 Million |
| Depreciation & Amortization | 35.74 Million | 39.18 Million | 37.7 Million | 14.46 Million | 3.3 Million |
| Deferred income taxes | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - |
| Change in working capital | 365.29 Million | -139.53 Million | 502.36 Million | -221.41 Million | 243.34 Million |
| Other non-cash items | -9.98 Million | 24.94 Million | -66.83 Million | 3.13 Million | -3 Million |
| Investing Cash Flow | -12 Million | -54.02 Million | -72.22 Million | -43.6 Million | -4.4 Million |
| Investments in PPE | -12 Million | -48.75 Million | -72.22 Million | -45.35 Million | -4.33 Million |
| Acquisitions | - | - | - | - | - |
| Investment purchases | - | - | - | - | -338 Thousand |
| Sales/Maturities of investments | - | - | - | 4.66 Million | - |
| Other Investing Activities | - | -5.27 Million | - | -2.91 Million | -72 Thousand |
| Financing Cash Flow | 35.73 Million | 1.01 Billion | -18.53 Million | 236.97 Million | 18.58 Million |
| Debt repayment | -22.44 Million | -84.48 Million | -18.53 Million | -181.39 Million | -11.42 Million |
| Dividends payments | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - |
| Common Stock Issuance | 58.17 Million | 1.1 Billion | - | 55 Million | 30 Million |
| Other Financing Activities | 57 Million | -1000.00 | - | 582 Thousand | - |
| Accounts receivables | -173 Thousand | -13 Million | 144 Million | -141.44 Million | 4.13 Million |
| Accounts payables | -12.24 Million | 15.19 Million | -17.01 Million | 6.48 Million | -10.22 Million |
| Inventory | 69.64 Million | -46.58 Million | -85.23 Million | -112.15 Million | -14.04 Million |
| Other working capital | 292 Million | -53 Million | 425 Million | 34.24 Million | 263.48 Million |
| Cash at beginning of period | 2.16 Billion | 1.17 Billion | 610.77 Million | 380.67 Million | 103.66 Million |
| Cash at end of period | 1.88 Billion | 2.16 Billion | 1.17 Billion | 610.77 Million | 380.67 Million |
| Capital Expenditure | -12 Million | -48.75 Million | -72.22 Million | -45.35 Million | -4.33 Million |
| Effect of forex changes on cash | - | - | - | - | - |
| Net cash flow / Change in cash | -277.61 Million | 986.08 Million | 564.15 Million | 230.09 Million | 277.01 Million |
| Free Cash Flow | -313.35 Million | -20.26 Million | 582.68 Million | -8.62 Million | 258.5 Million |
| Breakdown | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 | 2023 Q1 | 2022 FY |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | -636.37 Million | 314 Million | -662 Million | -169 Million | -124 Million | 144.22 Million |
| Depreciation & Amortization | 35.74 Million | - | - | - | - | 39.18 Million |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 365.29 Million | - | - | - | - | -139.53 Million |
| Other non-cash items | -9.98 Million | -314 Million | 662 Million | 169 Million | 124 Million | 24.94 Million |
| Investing Cash Flow | -12 Million | - | - | - | - | -54.02 Million |
| Investments in PPE | -12 Million | - | - | - | - | -48.75 Million |
| Acquisitions | - | - | - | - | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | - | - | - | -5.27 Million |
| Financing Cash Flow | 35.73 Million | - | - | - | - | 1.01 Billion |
| Debt repayment | -22.44 Million | - | - | - | - | -84.48 Million |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | 58.17 Million | - | - | - | - | 1.1 Billion |
| Other Financing Activities | 57 Million | - | - | - | - | -1000.00 |
| Accounts receivables | -173 Thousand | - | - | - | - | -13 Million |
| Accounts payables | -12.24 Million | - | - | - | - | 15.19 Million |
| Inventory | 69.64 Million | - | - | - | - | -46.58 Million |
| Other working capital | 292 Million | - | - | - | - | -53 Million |
| Cash at beginning of period | 2.16 Billion | - | - | - | - | 1.17 Billion |
| Cash at end of period | 1.88 Billion | - | - | - | - | 2.16 Billion |
| Capital Expenditure | -12 Million | - | - | - | - | -48.75 Million |
| Effect of forex changes on cash | - | - | - | - | - | - |
| Net cash flow / Change in cash | -277.61 Million | - | - | - | - | 986.08 Million |
| Free Cash Flow | -313.35 Million | - | - | - | - | -20.26 Million |
023410
002210
023530
1381
NOBGY
HTHIF